154 related articles for article (PubMed ID: 35848686)
1. Evaluation of glycemic status among hypercholesterolemic patients on atorvastatin in a tertiary care hospital - A retrospective study.
Nalini R; Ramya JE; Karthick R
Indian J Pharmacol; 2022; 54(3):165-170. PubMed ID: 35848686
[TBL] [Abstract][Full Text] [Related]
2. Analysis of glycemic status in diabetes-naïve patients on statins: A hospital-based cross-sectional study.
Thomson SR; Chogtu B; Shetty R; Devasia T
Indian J Pharmacol; 2018; 50(6):320-325. PubMed ID: 30783324
[TBL] [Abstract][Full Text] [Related]
3. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
[TBL] [Abstract][Full Text] [Related]
4. Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study.
Trias F; Pintó X; Corbella E; Suárez-Tembra M; Ruíz-García A; Díaz-Díaz JL; Sánchez-Ruíz-Granado E; Sarasa I; Martínez-Porqueras R; Rodríguez-Sánchez MA; Corbella X;
Med Clin (Barc); 2022 Jun; 158(11):531-539. PubMed ID: 34517987
[TBL] [Abstract][Full Text] [Related]
5. The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients.
Kim TM; Kim H; Jeong YJ; Baik SJ; Yang SJ; Lee SH; Cho JH; Lee H; Yim HW; Choi IY; Yoon KH; Kim HS
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1156-1163. PubMed ID: 28556206
[TBL] [Abstract][Full Text] [Related]
6. Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial.
Park JB; Jung JH; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Sohn DW
Trials; 2017 Oct; 18(1):501. PubMed ID: 29078817
[TBL] [Abstract][Full Text] [Related]
7. Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes.
Thongtang N; Tangkittikasem N; Samaithongcharoen K; Piyapromdee J; Srinonprasert V; Sriussadaporn S
Vasc Health Risk Manag; 2020; 16():367-377. PubMed ID: 33061398
[TBL] [Abstract][Full Text] [Related]
8. Statins Are Associated With Increased Insulin Resistance and Secretion.
Abbasi F; Lamendola C; Harris CS; Harris V; Tsai MS; Tripathi P; Abbas F; Reaven GM; Reaven PD; Snyder MP; Kim SH; Knowles JW
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2786-2797. PubMed ID: 34433298
[TBL] [Abstract][Full Text] [Related]
9. A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Protection Union Study (CAMPUS).
Zhang J; Shao Y; Liu Y; Tao J
Cardiovasc Drugs Ther; 2018 Dec; 32(6):581-589. PubMed ID: 30187345
[TBL] [Abstract][Full Text] [Related]
10. Use of Statins and the Risk of Incident Diabetes: A Retrospective Cohort Study.
Olotu BS; Shepherd MD; Novak S; Lawson KA; Wilson JP; Richards KM; Rasu RS
Am J Cardiovasc Drugs; 2016 Oct; 16(5):377-90. PubMed ID: 27272032
[TBL] [Abstract][Full Text] [Related]
11. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
[TBL] [Abstract][Full Text] [Related]
12. Influences of statins on glucose tolerance in patients with type 2 diabetes mellitus.
Takano T; Yamakawa T; Takahashi M; Kimura M; Okamura A
J Atheroscler Thromb; 2006 Apr; 13(2):95-100. PubMed ID: 16733297
[TBL] [Abstract][Full Text] [Related]
13. Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus.
Yamakawa T; Takano T; Tanaka S; Kadonosono K; Terauchi Y
J Atheroscler Thromb; 2008 Oct; 15(5):269-75. PubMed ID: 18981652
[TBL] [Abstract][Full Text] [Related]
14. Acute onset and worsening of diabetes concurrent with administration of statins.
Ohmura C; Watada H; Hirose T; Tanaka Y; Kawamori R
Endocr J; 2005 Jun; 52(3):369-72. PubMed ID: 16006732
[TBL] [Abstract][Full Text] [Related]
15. The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.
Sattar NA; Ginsberg H; Ray K; Chapman MJ; Arca M; Averna M; Betteridge DJ; Bhatnagar D; Bilianou E; Carmena R; Ceška R; Corsini A; Erbel R; Flynn PD; Garcia-Moll X; Gumprecht J; Ishibashi S; Jambart S; Kastelein JJ; Maher V; da Silva PM; Masana L; Odawara M; Pedersen TR; Rotella CM; Salti I; Teramoto T; Tokgozoglu L; Toth PP; Valensi P; Vergès B
Atheroscler Suppl; 2014 Jun; 15(1):1-15. PubMed ID: 24840509
[TBL] [Abstract][Full Text] [Related]
16. Effect of Atorvastatin on blood ketone levels and glycemic control in patients with type 2 diabetes mellitus: A single arm pilot study.
Baul PB; Deepak AD; Kakkar M; Modi S
Diabetes Metab Syndr; 2020; 14(5):1333-1337. PubMed ID: 32755832
[TBL] [Abstract][Full Text] [Related]
17. Effects of statin therapy on glycemic control and insulin resistance: A systematic review and meta-analysis.
Alvarez-Jimenez L; Morales-Palomo F; Moreno-Cabañas A; Ortega JF; Mora-Rodríguez R
Eur J Pharmacol; 2023 May; 947():175672. PubMed ID: 36965747
[TBL] [Abstract][Full Text] [Related]
18. Statins: beneficial or adverse for glucose metabolism.
Sasaki J; Iwashita M; Kono S
J Atheroscler Thromb; 2006 Jun; 13(3):123-9. PubMed ID: 16835466
[TBL] [Abstract][Full Text] [Related]
19. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.
Anyanwagu U; Mamza J; Donnelly R; Idris I
Cardiovasc Diabetol; 2017 Aug; 16(1):107. PubMed ID: 28830436
[TBL] [Abstract][Full Text] [Related]
20. Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes.
Huang CH; Huang YY; Hsu BR
J Diabetes Investig; 2016 Sep; 7(5):769-76. PubMed ID: 27181110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
